102818-67-7

Basic information

• Product Name: (-)-2-(4-Chlorphenyl)-3-methyl-1,3-thiazinan-4-on-1,1-dioxid
• Synonyms: (-)-2-(4-Chlorphenyl)-3-methyl-1,3-thiazinan-4-on-1,1-dioxid
• CAS NO: 102818-67-7
• Molecular Weight: 273.74
• Mol File: 102818-67-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (-)-2-(4-Chlorphenyl)-3-methyl-1,3-thiazinan-4-on-1,1-dioxid(CAS DataBase Reference)
• NIST Chemistry Reference: (-)-2-(4-Chlorphenyl)-3-methyl-1,3-thiazinan-4-on-1,1-dioxid(102818-67-7)
• EPA Substance Registry System: (-)-2-(4-Chlorphenyl)-3-methyl-1,3-thiazinan-4-on-1,1-dioxid(102818-67-7)

Safety Data

• Hazardous Substances Data: 102818-67-7(Hazardous Substances Data)

Upstream product

• 30897-26-8 2-(4-Chlorophenyl)-3-methyl-3,4,5,6-tetrahydro-2H-1,3-thiazin-4-on 
• 102818-66-6 chlormezanone 
• 104-88-1 4-chlorobenzaldehyde 
• 102818-66-6 (+)-2-(4-Chlorphenyl)-3-methyl-1,3-thiazinan-4-on-1,1-dioxid 

Downstream Products

• 102818-66-6 (+)-2-(4-Chlorphenyl)-3-methyl-1,3-thiazinan-4-on-1,1-dioxid 
• 102818-66-6 chlormezanone 
• 104-88-1 4-chlorobenzaldehyde 
• 77711-05-8 3-sulfinopropionic acid 
• 74-89-5 methylamine 

Relevant articles and documents

FURTHER FUNCTIONAL GROUP OXIDATIONS USING SODIUM PERBORATE

Sodium perborate in acetic acid is an effective reagent for the oxidation of aromatic aldehydes to carboxylic acids, iodoarenes to (diacetoxyiodo)arenes, azines to N-oxides, and various types of sulfur heterocycles to S,S-dioxides.Nitriles are unaffected by the reagent in acetic acid, but undergo smooth hydration to amides when aqueous methanol is employed as solvent.

New results on the synthesis of the centrally acting muscle relaxant chlormezanone and its resolution on a gram scale using a Chiralcel OD column

2-(4-Chlorophenyl)-4-metathiazanone (2) is the intermediate product for the two step-synthesis of chlormezanone (1), a centrally acting muscle relaxant. The second step includes the oxidation of its sulfur atom. It has been found that the foregoing reacti

Water dispersion containing ultrafine particles of organic compounds

A water-dispersible condensate of water-insoluble ultrafine particles of medicine or hormones having a particle size of at largest 4 μm prepared by the steps of heating the medicine or hormone in a vacuum vessel at a temperature of 30° C. higher than the boiling point and at a pressure between 0.01 Torr and 10 Torr to evaporate the medicine or hormone and condensing the medicine or hormone on a recovery plate to obtain the condensate.